Product Description
Galectin-9 (Gal-9) is a member of animal lectins that have an affinity to beta-galactosides and Forssman pentasaccharide. It is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. Recombinant Galectin-9 protein was expressed in E.coli and purified by using conventional chromatography techniques.
Biovision | 7365 | Galectin-9 human recombinant DataSheet
Biomolecule/Target: Galectin-9
Synonyms: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9
Alternates names: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9
Taglines: A protein strongly overexpressed in Hodgkin's disease tissue.
NCBI Gene ID #: 2254
NCBI Gene Symbol: FGF9
Gene Source: Human
Accession #: P54130
Recombinant: Yes
Source: E. coli
Purity by SDS-PAGEs: 98%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: N/A
Activity (Specifications/test method): N/A
Biological activity: The ED50 for this effect is equal to or less than 2.5 µg/ml. Measured by its ability to agglutinate human red blood cells.
Results: N/A
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: 18.5 kDa (168 aa, 1-148 aa + His Tag).
Concentration: 0.5 mg/ml
Appearance: Liquid
Physical form description: 0.5 mg/ml in 20 mM Tris-HCl buffer (pH 8.0) containing 1 mM NaCl and 20% glycerol.
Reconstitution Instructions: N/A
Amino acid sequence: MGSSHHHHHH SSGLVPRGSH MAFSGSQAPY LSPAVPFSGT IQGGLQDGLQ ITVNGTVLSS SGTRFAVNFQ TGFSGNDIAF HFNPRFEDGG YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV QYFHRVPFHR VDTISVNGSV QLSYISFQ